Clinical Trial Update: Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating stereotactic body radiation therapy combined with Avelumab immunotherapy for malignant mesothelioma has posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Avelumab (avelumab)
• Stereotactic Body Radiation Therapy (SBRT)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Mesothelioma (MPM) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-10-23